Atherosclerosis Risk and Treatment Evaluation towards Risk Reduction Epidemiology

  • Bérard E, Bongard V, Haas B, Dallongeville J, Moitry M, Cottel D, Ruidavets JB, Ferrières J. Prevalence and Treatment of Familial Hypercholesterolemia in France. Can J Cardiol. 2019 Jun;35(6):744-752. doi: 10.1016/j.cjca.2019.02.013. abstract
  • Ferrières J, De Ferrari GM, Hermans MP, Elisaf M, Toth PP, Horack M, Brudi P,  Lautsch D, Bash LD, Baxter CA, Ashton V, Ambegaonkar B, Gitt AK. Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: Results from DYSIS II Europe. Eur J Prev Cardiol. 2018 Dec;25(18):1966-1976. doi: 10.1177/2047487318806359. abstract
  • Ferrières J, Lautsch D, Gitt AK, De Ferrari G, Toplak H, Elisaf M, Drexel H, Horack M, Baxter C, Ambegaonkar B, Brudi P, Toth PP. Body mass index impacts the  choice of lipid-lowering treatment with no correlation to blood cholesterol - Findings from 52 916 patients in the Dyslipidemia International Study (DYSIS). Diabetes Obes Metab. 2018 Nov;20(11):2670-2674. doi: 10.1111/dom.13415. abstract
  • Séguro F , Rabès JP, Taraszkiewicz D, Ruidavets JB, Bongard V, Ferrières J. Genetic diagnosis of familial hypercholesterolemia is associated with a premature and high coronary heart disease risk. Clin Cardiol. 2018 Mar;41(3):385-391. doi:  10.1002/clc.22881. abstract
  • Bérard E, Bongard V, Haas B, Dallongeville J, Moitry M, Cottel D, Ruidavets JB, Ferrières J. Score of Adherence to 2016 European Cardiovascular Prevention Guidelines Predicts Cardiovascular and All-Cause Mortality in the General Population. Can J Cardiol. 2017 Oct;33(10):1298-1304. doi: 10.1016/j.cjca.2017.06.008. abstract
  • Panh  L, Ruidavets JB, Rousseau H, Petermann A, ongard V, Bérard E, Taraszkiewicz D, Lairez O, Galinier M, Carrié D, Ferrières J. Association between serum alkaline phosphatase and coronary artery calcification in a sample of primary cardiovascular prevention patients. Atherosclerosis. 2017 May;260:81-86.  doi: 10.1016/j.atherosclerosis. abstract
  • André R, Bongard V, Elosua R, Kirchberger I, Farmakis D, Häkkinen U, Fusco D, Torre M, Garel P, Araújo C, Meisinger C, Lekakis J, Malmivaara A, Dovali M, Pereira M, Marrugat J, Ferrières J. International differences in acute coronary syndrome patients' baseline characteristics, clinical management and outcomes in Western Europe: the EURHOBOP study. Heart. 2014. 100(15):1201-7. doi: 10.1136/heartjnl-2013-305196. abstract
  • Huo Yung Kai S V, Bongard V, Simon C, Ruidavets JB, Arveiler D, Dallongeville J, Wagner A, Amouyel P, Ferrières J. Low-fat and high-fat dairy products are differently related to blood lipids and cardiovascular risk. Eur J Prev Cardiol.  2014. 21(12):1557-67.  doi: 10.1177/2047487313503283 abstract
  • Bongard V, Dallongeville J, Arveiler D, Ruidavets JB, Amouyel P, Wagner A, Ferrières J. Attainment of low-density lipoprotein cholesterol target in the French general population according to levels of cardiovascular risk: Insights from the MONA LISA study. Arch Cardiovasc Dis.2013.106(2): 93-102. doi: 10.1016/j.acvd.2012.11.003. abstract
  • Vervueren PL, Elbaz M, Dallongeville J, Arveiler D, Ruidavets JB, Montaye M, Wagner A, Amouyel P, Haas B, Bongard V, Ferrières J. Relationships between chronic use of statin therapy, presentation of acute coronary syndromes and one-year mortality after an incident acute coronary event. Int J Cardiol.2013.163(1):102-4. doi: 10.1016/j.ijcard.2012.06.112. abstract
  • Hascoët S, Elbaz M, Bongard V, Bouisset F , Verdier C, Vindis C, Genoux A, Taraszkiewicz D, Perret B, Galinier M, Carrié D, Ferrières J, Ruidavets JB. Adiponectin and long-term mortality in coronary artery disease participants and controls. Arterioscler Thromb Vasc Biol. 2013.33(1):e19-29. abstract
  • Vervueren PL, Elbaz M, Wagner A, Dallongeville J, Ruidavets JB, Haas B, Montaye M, Bongard V, Arveiler D, Amouyel P, Ferrières J. The major element of 1-year prognosis in acute coronary syndromes is severity of initial clinical presentation: Results from the French MONICA registries. Arch Cardiovasc Dis.2012.105(10):478-88. doi: 10.1016/j.acvd.2012.05.008. abstract
  • Puymirat E, Simon T, Steg PG, Schiele F, Guéret P, Blanchard D, Khalife K, Goldstein P, Cattan S, Vaur L, Cambou JP, Ferrières J, Danchin N; USIK USIC 2000 Investigators; FAST MI Investigators. Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction. JAMA.2012.308(10):998-1006.  doi: 10.1001/2012.jama.11348. abstract
  • Bouisset F, Bongard V, Ruidavets JB, Hascoët S, Taraszkiewicz D, Roncalli J, Carrié D, Galinier M, Elbaz M, Ferrières J. Prognostic usefulness of clinical and subclinical peripheral arterial disease in men with stable coronary heart disease. Am J Cardiol.2012.110(2)197-202.doi: 10.1016/j.amjcard.2012.03.013. abstract
  • Esquirol Y, Perret B, Ruidavets JB, Marquié JC, Dienne E, Niezborala M, Ferrières J. Shift work and cardiovascular risk factors: new knowledge from the past decade. Ach Cardiovasc Dis.2011.104(12):636-68.doi: 10.1016/j.acvd.2011.09.004. abstract
  • Bérard E, Bongard V, Dallongeville J, Arveiler D, Ruidavets JB, Ferrières J. Cancer mortality according to lipid-lowering drugs and lipoproteins in a general population. Curr Med Res Opin.2011.27(10):1963-71.doi: 10.1185/03007995.2011.616191. abstract
  • Ruidavets JB, Ducimetière P, Evans A, Montaye M, Haas B, Bingham A, Yarnell J, Amouyel P, Arveiler D, Kee F, Bongard V, Ferrières J. Patterns of alcohol consumption and ischaemic heart disease in culturally divergent countries: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). BMJ. 2010. 341:c6077. doi: 10.1136/bmj.c6077. abstract
  • Benguigui C, Bongard V, Ruidavets JB, Chamontin B, Sixou M, Ferrières J, Amar J. Metabolic syndrome, insulin resistance, and periodontitis: a cross-sectional study in a middle-aged French population. J Clin Periodontol.2010.37(7):601-8.doi: 10.1111/j.1600-051X.2010.01571.x. abstract
  • Cournot M, Taraszkiewicz D, Cambou JP, Galinier M, Boccalon H, Hanaire-Broutin H, Chamontin B, Carrié D, Ferrières J. Additional prognostic value of physical examination, exercise testing, and arterial ultrasonography for coronary risk assessment in primary prevention. Am Heart J.2009.158(5):845-51. doi: 10.1016/j.ahj.2009.08.017. abstract
  • Ferrières J, Bataille V, Leclercq F, Geslin P, Ruidavets JB, Grollier G, Bernard P, Cambou JP, Simon T, Danchin N.Patterns of statin prescription in acute myocardial infarction: the French registry of Acute ST-elevation or non-ST-elevation Myocardial Infarction (FAST-MI). Atherosclerosis.2009. 204(2):491-6. doi: 10.1016/j.atherosclerosis.2008.09.031. abstract
  • Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet E, Méneveau N, Steg PG, Ferrières J, Danchin N, Becquemont L; French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators. Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med. 2009.360:363-75.doi: 10.1056/NEJMoa0808227. abstract
  • Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, Alessi MC, Chamontin B, Ferrières J. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr. 2008.87(5):1219-23. abstract
  • Cournot M, Boccalon H, Cambou JP, Guilloux J, Taraszkiewicz D, Hanaire-Broutin H, Chamontin B, Galinier M, Ferrières J. Accuracy of the screening physical examination to identify subclinical atherosclerosis and peripheral arterial disease in asymptomatic subjects. J Vasc Surg.2007.46(6):1215-21. abstract
  • Ruidavets JB, Bongard V, Dallongeville J, Arveiler D, Ducimetière P, Perret B, Simon C, Amouyel P, Ferrières J. High consumptions of grain, fish, dairy products and combinations of these are associated with a low prevalence of metabolic syndrome. J Epidemiol Community Health.2007.61:810-17. abstract